To investigate whether DEPDC1 was a potentially as a prognostic marker, the overall survival (OS), and disease-free survival (DFS) time of breast cancer patients from the follow-up data were performed by Kaplan-Meier survival analysis. Here, DEPDC1 is linked to breast carcinoma.